Tim Oldham, CEO and Managing Director, AdAlta (ASX:1AD) is a clinical stage biotechnology company using its i-body platform to discover and develop next generation protein therapeutics addressing drug targets that are challenging fot other technologies,
Beginning of dialog window. Escape will cancel and close the window.
End of dialog window.
Tim Oldham, CEO and Managing Director, AdAlta (ASX:1AD) is a clinical stage biotechnology company using its i-body platform to discover and develop next generation protein therapeutics addressing drug targets that are challenging fot other technologies,
Post Views:161
Serving up fresh finance news, marker movers & expertise.
